PharmGen Science, Inc. (KRX:004720)

PharmGen Science Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Feb 12, 2025	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	80,265	111,355	105,470	159,511	165,783	74,173
Market Cap Growth	-16.03%	5.58%	-33.88%	-3.78%	123.51%	-13.05%
Enterprise Value	84,663	127,335	126,753	178,736	154,760	77,274
Last Close Price	4420.00	6200.00	6680.00	10500.00	11300.00	6370.00
PE Ratio	-	19.44	1.51	4.91	17.98	245.62
PS Ratio	0.46	0.67	0.70	1.45	1.72	0.78
PB Ratio	0.35	0.49	0.51	1.26	1.98	1.32
P/TBV Ratio	0.39	0.49	0.51	1.26	1.99	1.34
P/FCF Ratio	32.44	35.09	-	-	-	-
P/OCF Ratio	26.69	20.47	-	20.49	61.96	29.39
EV/Sales Ratio	0.49	0.76	0.84	1.63	1.60	0.81
EV/EBITDA Ratio	6.79	9.52	11.76	-	146.36	21.96
EV/EBIT Ratio	10.81	13.95	17.10	-	-	64.54
EV/FCF Ratio	34.22	40.13	-	-	-	-
Debt / Equity Ratio	0.17	0.17	0.19	0.38	0.26	0.35
Debt / EBITDA Ratio	2.20	2.84	3.66	-	20.24	5.62
Debt / FCF Ratio	15.54	11.96	-	-	-	-
Asset Turnover	0.51	0.51	0.56	0.62	0.82	0.96
Inventory Turnover	2.47	3.32	3.87	3.11	2.85	3.48
Quick Ratio	1.15	1.16	0.70	0.76	1.38	1.16
Current Ratio	1.62	1.51	1.03	1.09	1.99	1.67
Return on Equity (ROE)	-0.55%	2.63%	41.95%	30.80%	13.05%	0.42%
Return on Assets (ROA)	2.35%	1.75%	1.72%	-1.73%	-1.01%	0.76%
Return on Capital (ROIC)	2.96%	2.22%	2.20%	-2.21%	-1.32%	0.98%
Return on Capital Employed (ROCE)	4.67%	3.35%	2.97%	-	-	1.72%
Earnings Yield	-1.54%	5.14%	66.43%	20.35%	5.56%	0.41%
FCF Yield	3.08%	2.85%	-10.63%	-14.40%	-1.00%	-4.90%
Buyback Yield / Dilution	1.35%	3.68%	-16.09%	-23.81%	-30.15%	3.86%
Total Shareholder Return	1.35%	3.68%	-16.09%	-23.81%	-30.15%	3.86%

Source: S&P Capital IQ. Standard template. Financial Sources.